BORSI, ENRICA
 Distribuzione geografica
Continente #
NA - Nord America 1.909
EU - Europa 1.374
AS - Asia 717
AF - Africa 106
Totale 4.106
Nazione #
US - Stati Uniti d'America 1.898
IT - Italia 376
GB - Regno Unito 307
CN - Cina 280
SG - Singapore 199
SE - Svezia 190
DE - Germania 165
IN - India 102
VN - Vietnam 99
IE - Irlanda 67
RU - Federazione Russa 50
FR - Francia 46
TG - Togo 36
CI - Costa d'Avorio 28
ZA - Sudafrica 27
EE - Estonia 26
FI - Finlandia 25
BG - Bulgaria 24
CH - Svizzera 22
UA - Ucraina 17
NG - Nigeria 15
NL - Olanda 13
CA - Canada 11
BE - Belgio 10
IR - Iran 10
AT - Austria 9
ES - Italia 8
JO - Giordania 8
ID - Indonesia 6
RO - Romania 5
HK - Hong Kong 4
PH - Filippine 4
CZ - Repubblica Ceca 3
PT - Portogallo 2
RS - Serbia 2
CY - Cipro 1
GR - Grecia 1
HR - Croazia 1
HU - Ungheria 1
KR - Corea 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
PL - Polonia 1
TR - Turchia 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 4.106
Città #
Southend 284
Chandler 262
Fairfield 204
Singapore 169
Ashburn 162
Bologna 118
Ann Arbor 108
Wilmington 87
Woodbridge 83
Houston 78
Seattle 78
Princeton 70
Dublin 67
Cambridge 66
Santa Clara 52
Boardman 49
Dong Ket 45
Lomé 36
Beijing 34
Hyderabad 32
Nanjing 31
Abidjan 28
Milan 28
Westminster 28
Fabriano 27
Padova 26
New York 25
Bremen 24
Sofia 24
Berlin 23
Helsinki 23
Salsomaggiore Terme 20
Redmond 19
Bern 17
Jinan 17
Turin 15
Abeokuta 14
Saint Petersburg 14
Medford 13
Shenyang 13
Los Angeles 12
Hebei 11
Nanchang 11
Redwood City 11
Washington 11
Brussels 10
Falls Church 9
Mondolfo 9
Amman 8
Florence 8
Guangzhou 8
Vienna 8
Wuhan 8
Amsterdam 7
Changsha 7
Hangzhou 7
Norwalk 7
Rome 7
San Diego 7
Toronto 7
Coimbatore 6
Jakarta 6
Jiaxing 6
Kuban 6
Shanghai 6
Tianjin 6
Zhengzhou 6
Paris 5
Reggio Emilia 5
Riola 5
Ardabil 4
Casalecchio di Reno 4
Como 4
Dearborn 4
Des Moines 4
Hong Kong 4
Modena 4
Monmouth Junction 4
Olalla 4
Parma 4
Romainville 4
San Lazzaro Di Savena 4
Shenzhen 4
Taizhou 4
Boydton 3
Bühl 3
Carpi 3
Frankfurt am Main 3
Geneva 3
Groningen 3
Haikou 3
Lanzhou 3
Las Vegas 3
Munich 3
Mülheim 3
Ningbo 3
San Francisco 3
Springfield 3
Stilo 3
Bari 2
Totale 2.846
Nome #
Bortezomib-based therapy combined with high cut-off hemodialysis is highly effective in newly diagnosed multiple myeloma patients with severe renal impairment 198
Chibby drives β catenin cytoplasmic accumulation leading to activation of the unfolded protein response in BCR-ABL1+ cells 162
The genetic and genomic background of multiple myeloma patients achieving complete response after induction therapy with bortezomib, thalidomide and dexamethasone (VTD) 161
Hypoxia inducible factor-1 alpha as a therapeutic target in multiple myeloma. 141
Opposite activation of the Hedgehog pathway in CD138+ plasma cells and CD138-CD19+ B cells identifies two subgroups of patients with multiple myeloma and different prognosis 136
Prognostic impact of serial measurements of serum-free light chain assay throughout the course of newly diagnosed multiple myeloma treated with bortezomib-based regimens 133
Treatment optimization for Multiple Myeloma: schedule-dependent synergistic cytotoxicity of pomalidomide and carfilzomib in an in vitro and ex-vivo model 133
Cap dependent translation contributes to resistance of myeloma cells to bortezomib 127
Genomic characterization of the putative myeloma stem cells clone reveals alterations possibly correlated with the origin of disease. 127
Gadd45a transcriptional induction elicited by the Aurora kinase inhibitor MK-0457 in Bcr-Abl-expressing cells is driven by Oct-1 transcription factor 125
High Number of Copy Number Alterations and Over-Expression of Genes Involved in the Response Mechanisms to Genotoxic Stress Both Characterize Newly Diagnosed Multiple Myeloma (MM) Patients Carrying Amplified MDM4 and/or Deleted p53 122
Inter-Cell Networking Profiling Enables Comprehensive Characterization of Immune-Mediated Activity of Anti-CD38 Therapy through Ex-Vivo Analysis of Multiple Myeloma Patients 120
HIF-1α inhibition blocks the cross talk between multiple myeloma plasma cells and tumor microenvironment 118
PET/CT Improves the Definition of Complete Response and Allows to Detect Otherwise Unidentifiable Skeletal Progression in Multiple Myeloma 118
Analysis of mismatch repair gene mutations in Turkish HNPCC patients 118
Clonal and subclonal TP53 molecular impairment is associated with prognosis and progression in multiple myeloma 117
Cytoplasmatic compartmentalization by Bcr-Abl promotes TET2 loss-of-function in chronic myeloid leukemia 116
HIF 1 Alpha: A Suitable Target for Multiple Myeloma 110
Maintenance therapy with bortezomib and dexamethasone after autotransplantation for high-risk multiple myeloma 110
SIRT regulates the molecular interaction between c-MYC and HIF-1 alpha in multiple myeloma 104
Relative role ofAPCandMUTYHmutations in the pathogenesis of familial adenomatous polyposis 103
Gene expression analysis of newly diagnosed Multiple Myeloma (MM) patients carrying amplified MDM4 and/or deleted p5 101
HIF-1a INHIBITION PROMOTES CELL CYCLE ARREST IN MULTIPLE MYELOMA 99
null 98
Impact Of p53 Impaired Function On Outcomes Of Multiple Myeloma Patients Carrying Deleted TP53 and/Or Amplified MDM4 97
Therapeutic targeting of hypoxia and hypoxia-inducible factor 1 alpha in multiple myeloma 97
High CNA level and over-expression of genes involved in response mechanisms to genotoxic stress characterize newly diagnosed Multiple Myeloma (MM) patients carrying amplified MDM4 and/or deleted TP53 94
BoBafit: A copy number clustering tool designed to refit and recalibrate the baseline region of tumors’ profiles 83
VarianThinker: a classification method to confidently approach the mutation heterogeneity in Multiple Myeloma 80
AIRTUM numbers: 200,000 young Italians live with cancer 79
Identification of a Maturation Plasma Cell Index through a Highly Sensitive Droplet Digital PCR Assay Gene Expression Signature Validation in Newly Diagnosed Multiple Myeloma Patients 73
A Methodologically Updated De-Novo Extraction of Copy Number Signatures in Multiple Myeloma: Clinical Significance and Putative Aetiologies 71
[Italian cancer figures, report 2010: Cancer prevalence in Italy. Patients living with cancer, long-term survivors and cured patients]. 71
[Italian cancer figures, report 2011: Survival of cancer patients in Italy]. 65
Italian cancer figures, report 2012: Cancer in children and adolescents. 62
The ALLgorithMM: How to define the hemodilution of bone marrow samples in lymphoproliferative diseases 60
Loss of nuclear beta catenin, following chibby enforced expression, activates endoplasmic reticulum stress in cells expressing the BCR-ABL1 fusion gene of chronic myeloid leukemia 55
Single-Cell DNA Sequencing Reveals an Evolutionary Pattern of CHIP in Transplant Eligible Multiple Myeloma Patients 48
Long term follow-up of humoral and cellular response to mRNA-based vaccines for SARS-CoV-2 in patients with active multiple myeloma 40
OAB-057: Temporal-weight estimation of the copy number alterations of of 1384 Multiple Myeloma patients defines an ancestrality index impacting patients survival 31
Multi-dimensional scaling techniques unveiled gain1q&loss13q co-occurrence in Multiple Myeloma patients with specific genomic, transcriptional and adverse clinical features 28
Circulating Multiple Myeloma Cells (CMMCs) as Prognostic and Predictive Markers in Multiple Myeloma and Smouldering MM Patients 27
Rare, but complex chromosomal rearrangements, defined "Chromoanagenesis”, caused by single-step or stepwise catastrophic genomic events, significantly impact on Multiple Myeloma patients 23
OAB-006: A novel algorithm to identify, characterize and define the prognostic impact of complex catastrophic events in Multiple Myeloma 21
High levels of CRBN isoform lacking IMiDs binding domain predicts for a worse response to IMiDs-based upfront therapy in newly diagnosed myeloma patients 21
Abstract 2700: Negative selective pressure exerted by maintenance therapy promotes the extinction of sub-clones carrying high-risk lesions in multiple myeloma 14
Totale 4.237
Categoria #
all - tutte 12.547
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.547


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020445 0 0 0 0 0 0 98 106 113 48 33 47
2020/2021398 74 23 6 9 13 16 6 20 60 13 11 147
2021/2022742 32 36 41 48 65 41 20 41 42 103 121 152
2022/20231.009 80 133 43 153 79 83 30 47 144 57 81 79
2023/2024450 32 44 46 37 30 86 26 84 12 13 24 16
2024/2025608 81 130 105 111 119 56 6 0 0 0 0 0
Totale 4.237